ABSTRACT
Aim To explore specific mechanisms of a board game aiming to facilitate peer support among people with type 2 diabetes.
Design Qualitative observational study including game tests in group-based diabetes education programs and focus groups exploring experiences among people with type 2 diabetes playing the game.
Methods The game was tested with 77 people with type 2 diabetes in March-July 2019. Data from audio recordings of game tests and focus groups were analysed using interpretive description.
Results Six mechanisms facilitated peer support among people with type 2 diabetes: 1) entering a safe space of normality created by emotional in-game mirroring; 2) mutual in-game acknowledgment of out-of-game efforts; 3) forming relationships through in-game humor; 4) health care professionals using game rules to support group dialogues of interest to people with type 2 diabetes; 5) being inspired by in-game exchange of tips and tricks; and 6) co-players guiding each other during the game. Peer support was inhibited by the mechanism of game rules obstructing group dialogues.
Conclusion The board game effectively facilitated peer support through playfulness and humor and helped players form relationships. Additionally, the game established a framework for players to share and listen to each other’s diabetes-specific experiences, promoting a sense of normality and cohesiveness. This process depended on facilitating educators’ flexibility to balance the rules of the game with its aim of creating peer support.
Impact
The study provides detailed knowledge on specific board game mechanisms facilitating peer support among people with type 2 diabetes participating in diabetes education programs.
The game was an effective tool to facilitate emotional and practical peer support by encouraging players to share and acknowledge each other’s diabetes experiences.
Peer support is promoted through the game by creating a sense of normality and belonging among people with type 2 diabetes.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
The study is registerd at Center for Open Science with the following identifier: DOI 10.17605/OSF.IO/ZHJ5E
Funding Statement
Financial support to conduct the study was provided by Steno Diabetes Center Copenhagen. No external funding was received.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Data Protection Agency (project ID: VD-2018-157) and conducted according to the Helsinki Declaration (WMA General Assembly, 2018, July 9) and current Danish legislation.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.